Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)
Johnson & Johnson (JNJ) posted Inventory Average of $14.9 billion for Q2 2026, up 3.31% sequentially from $14.4 billion in Q1 2026, and up 14.02% YoY from $13.0 billion in Q2 2025.
Johnson & Johnson (JNJ) Inventory Average (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Inventory Average for 18 years, with the latest figure at $14.9 billion in Q2 2026.
- Quarterly Inventory Average rose 14.02% year-over-year to $14.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.9 billion (up 14.02% YoY) and the FY2025 annual result came in at $13.3 billion, up 12.74% from the prior year.
- Inventory Average improved to $14.9 billion in Q2 2026 per JNJ's latest filing, from $14.4 billion in the prior quarter.
- Over five years, Inventory Average peaked at $14.9 billion in Q2 2026 and troughed at $10.4 billion in Q1 2022.
- A 5-year average of $12.3 billion and a median of $12.0 billion in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2026: Inventory Average declined 8.35% in 2024, then grew 14.62% in 2026.
- Over 5 years, Inventory Average stood at $11.6 billion in 2022, then fell by 3.17% to $11.2 billion in 2023, then gained by 11.92% to $12.5 billion in 2024, then gained by 13.14% to $14.2 billion in 2025, then advanced by 4.91% to $14.9 billion in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $14.9 billion, $14.4 billion, and $14.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 14.86 Bn |
| Mar 29, 2026 | 14.39 Bn |
| Dec 28, 2025 | 14.17 Bn |
| Sep 28, 2025 | 13.78 Bn |
| Jun 29, 2025 | 13.04 Bn |
| Mar 30, 2025 | 12.55 Bn |
| Dec 29, 2024 | 12.52 Bn |
| Sep 29, 2024 | 12.39 Bn |
| Jun 30, 2024 | 11.78 Bn |
| Mar 31, 2024 | 11.28 Bn |
| Dec 31, 2023 | 11.19 Bn |
| Oct 1, 2023 | 12.04 Bn |
| Jul 2, 2023 | 12.85 Bn |
| Apr 2, 2023 | 11.54 Bn |
| Jan 1, 2023 | 10.97 Bn |
| Oct 2, 2022 | 11.56 Bn |
| Jul 3, 2022 | 11.21 Bn |
| Apr 3, 2022 | 10.69 Bn |
| Jan 2, 2022 | 10.39 Bn |
| Oct 3, 2021 | 10.24 Bn |